Safety and Efficacy of Liposomal Cytarabine in Combination With Radiotherapy (RT) and Lomustine for the Treatment of Leptomeningeal Metastasis From Malignant Melanoma
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
The primary endpoint is safety and tolerance and will be based on the frequency and severity of adverse events.
Martin Glas, PD Dr.
Neurologische Universitaetsklinik Bonn
Germany: Federal Institute for Drugs and Medical Devices